HELIX BIOPHARMHELIX BIOPHARMHELIX BIOPHARM

HELIX BIOPHARM

No trades
See on Supercharts
Market capitalization
‪40.73 M‬CAD
−0.030CAD
‪−6.29 M‬CAD
‪175.75 M‬
Beta (1Y)
0.95

About HELIX BIOPHARM

CEO
Jacek Antas
Headquarters
Toronto
Employees (FY)
7
Founded
1995
ISIN
CA4229101098
FIGI
BBG0086JZD89
Helix BioPharma Corp. is an immuno-oncology company, which engages in the development of products for the treatment and prevention of cancer. It also funds research through issuance of common shares and warrants. The company was founded by Jerome F. McElroy on July 31, 1995 and is headquartered in Toronto, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of HBP is 0.175 CAD — it has decreased by 25.53% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange HELIX BIOPHARM stocks are traded under the ticker HBP.
HELIX BIOPHARM is going to release the next earnings report on Jun 11, 2024. Keep track of upcoming events with our Earnings Calendar.
HBP stock is 34.29% volatile and has beta coefficient of 0.95. Check out the list of the most volatile stocks — is HELIX BIOPHARM there?
HBP earnings for the last quarter are −0.02 CAD per share, whereas the estimation was −0.02 CAD resulting in a 0% surprise. The estimated earnings for the next quarter are −0.02 CAD per share. See more details about HELIX BIOPHARM earnings.
Yes, you can track HELIX BIOPHARM financials in yearly and quarterly reports right on TradingView.
HBP stock has fallen by 25.53% compared to the previous week, the month change is a 25.53% fall, over the last year HELIX BIOPHARM has showed a 12.50% decrease.
HBP net income for the last quarter is ‪−1.25 M‬ CAD, while the quarter before that showed ‪−2.15 M‬ CAD of net income which accounts for 41.78% change. Track more HELIX BIOPHARM financial stats to get the full picture.
No, HBP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HBP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HELIX BIOPHARM stock right from TradingView charts — choose your broker and connect to your account.
HBP reached its all-time high on Mar 5, 2020 with the price of 2.030 CAD, and its all-time low was 0.160 CAD and was reached on Aug 4, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 7.00 employees. See our rating of the largest employees — is HELIX BIOPHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HELIX BIOPHARM technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HELIX BIOPHARM stock shows the sell signal. See more of HELIX BIOPHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.